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ANTIMICROBIAL ACTIVITY OF GLUCOPROTAMIN: 
A CLINICAL STUDY OF A N E W DISINFECTANT FOR 
INSTRUMENTS 
Andreas F. Widmer, MD, MS; Reno Frei, MD, FAMH 
ABSTRACT 
OBJECTIVE: To determine the in vitro efficacy of gluco-
protamin for the disinfection of instruments. 
DESIGN: Prospective observational study. 
SETTING: University women's hospital. 
METHODS: Instruments were immersed in saline solu-
tion after use, and glucoprotamin was added to a concentration of 
1.5% before soaking for 60 minutes. Biocidal activity was deter-
mined by the difference in colony-forming units (CFU) on instru-
ments before and after disinfection. 
RESULTS: One hundred thirty-seven instruments were col-
lected during 10 days and exposed to a 1.5% dilution of glucoprotamin 
without prior washing. Bioburden before disinfection ranged from 2 
x 105 to 7.1 x 107 CFU per instrument. Average bacterial killing was 
5.98 loglg CFU ± 0.48 under aerobic conditions and 6.75 log10 CFU ± 
0.54 under anaerobic conditions, despite the presence of large 
amounts of proteins on instruments that were frequently bloody. No 
vegetative bacteria were isolated in any sample after disinfection. 
CONCLUSION: This clinical study confirmed excellent 
in vitro efficacy of glucoprotamin without prior removal of pro-
teins and debris (Infect Control Hosp Epidemiol 2003;24:762-764). 
Semicritical devices must undergo reliable disin-
fection and preferably sterilization before reuse.1 
Aldehydes and phenolic agents are the preferred disin-
fectants for surgical instruments. Phenolics have excel-
lent detergent properties in addition to antimicrobial 
efficacy. They clean, dissolve proteins, and disinfect in 
one step. However, phenolics have limited activity against 
organisms such as Pseudomonas aeruginosa2-3 and 
Aspergillus fumigatus.* In addition, the residues of wasted 
phenolic agents raise environmental concerns. 
Glucoprotamin, a new disinfectant, is based on a conver-
sion product of L-glutamic acid and coco(C12/14)alkyl-
propylene-1.3-diamine (Figure).15'6 It provides advan-
tages similar to those of phenolics, but is significantly 
more active against bacteria and viruses. It is also envi-
ronmentally safe. 
Glucoprotamin is nonvolatile, easily dissolved in 
water, nonteratogenic, nonmutagenic, and easily degrad-
able according to Organization for Economic Cooperation 
and Development guidelines, and has excellent toxicolog-
ic properties. It is active in vitro against vegetative bacteria 
including mycobacteria, fungi, and viruses.16 Undiluted 
glucoprotamin is also effective against bacterial spores. It 
is highly active against mycobacteria that are usually diffi-
cult to kill by disinfectants. In fact, some glutaraldehyde-
resistant strains of Mycobacterium chelonae were efficient-
ly killed by glucoprotamin but not by other disinfecting 
agents.7 Glucoprotamin is licensed in Europe as a high-
level disinfectant for instruments and has, in part, replaced 
the use of phenolics and aldehydes. In contrast to aldehy-
des, glucoprotamin dilutions being used have limited activ-
ity against bacterial spores. Glucoprotamin is noncorro-
sive to metals and compatible with most materials used in 
healthcare. The recent crisis in Europe involving 
Creutzfeldt-Jakob disease and its new variant promoted 
the use of disinfectants not based on aldehyde. The active 
group of aldehydes (eg, the carbonylic group) binds to the 
amino groups of proteins and may impede the removal of 
prion proteins from surgical instruments. Several in vitro 
and experimental in vivo studies have been performed on 
glucoprotamin and published mainly in the non-English lit-
erature. However, there are no published studies of the in-
hospital use of glucoprotamin. 
M E T H O D S 
Sekusept Plus (Ecolab, Duesseldorf, Germany) con-
tains 25 g of glucoprotamin in 100 g of disinfectant concen-
trate, nonionic detergents, solvents, complexing agent, 
corrosion inhibitors, color, and fragrance. We tested the 
antimicrobial activity of this product against the germs cont-
aminating clinically used instruments from a women's hos-
pital. Used specula and forceps were collected, placed in ster-
ile plastic bags, and sent to the laboratory within 1 hour. 
Collection was performed during 10 consecutive days, with 
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FIGURE. Chemical structure of glucoprotamin (R = C12/14 H25/29). 
a mean of 7 specula and 6 forceps per day. Instruments were 
collected at noon, not later than 4 hours after use, and 
processed in the afternoon of the same day. No washing or 
cleaning procedure was allowed to be performed on these 
instruments. In the laboratory, instruments were immersed 
in 5 L of 0.9% NaCl. One milliliter of the solution was used to 
determine the bacterial density before the disinfection 
process. Plates with serial dilutions of 1:10,1:100, and 1:1,000 
were incubated under aerobic and anaerobic conditions. 
Immersed instruments were exposed by adding glucoprota-
min (Sekusept Plus) to a final concentration of 1.5% before 
soaking for 60 minutes. After filtration of a 500-mL aliquot, 
membranes (0.45-um pores) were rinsed with 500 mL of neu-
tralizer, followed by 0.9% NaCl (500 mL). The membranes 
were incubated on blood agar for 48 hours at 35° C. 
The disinfection activity was measured as a reduc-
tion factor determined by calculating the difference in 
log10 colony-forming units (CFU) before and after disin-
fection. The optimal concentration of the neutralizing 
agent (1% polysorbate 80, 0.3% lecithin, 0.1% histidine, and 
0.1% cysteine in 0.1 M of phosphate buffer at pH 7.4) was 
determined by serial dilution experiments. 
RESULTS 
A total of 137 instruments were studied: 73 specula 
and 64 forceps. All samples were included in the results. 
Instruments were visibly soiled with secretions, detritus, 
and blood before being immersed in the disinfection solu-
tion. The average bioburden per instrument used in the 
women's hospital was high, between 105 and 107 CFU per 
instrument (Table). Bacterial killing was more than 5 
log10 CFU (range, 5.01 to 7.17), even in the presence of 
large amounts of proteins (Table). No vegetative bacteria 
were isolated after the disinfection process. As expected 
from the in vitro tests, bacterial spores (mainly Bacillus 
and Clostridium species) remained viable in all samples 
after the disinfection process. However, bacterial density 
averaged less than 0.02 CFU/mL. To further analyze the 
effectiveness of glucoprotamin against C. difficile, a sus-
pension test was performed. Glucoprotamin reduced C. 
difficile by 3 log10 CFU or more. 
TABLE 
BIOBURDEN AND REDUCTION FACTORS AGAINST VEGETATIVE 
BACTERIA OBTAINED FROM THE INSTRUMENTS 
type of 
Incubation 
Aerobic 
Anaerobic 
Mean 
Bioburden* 
6.731og10± 0.54 
7.18 log10 ± 0.15 
*Colony-forming units per instrument ± standard deviation. 
Mean Reduction 
Factors After 
Exposure to 
Glucoprotamin* 
5.98 log10 ± 0.48 
6.75 log10 ± 0.54 
DISCUSSION 
Glucoprotamin is the first new disinfectant to 
emerge in decades. In this clinical trial, we confirmed the 
in vitro efficacy of glucoprotamin against bacteria on 
instruments after use in a women's hospital. Bacterial 
killing of more than 5 log10 CFU was observed after 1 
hour, although the instruments were not washed before 
the disinfection process. This first step of decontamina-
tion was omitted for study purposes to challenge the 
action of glucoprotamin to kill microorganisms in the 
presence of large volumes of proteins. Bacteria on conta-
minated surfaces are up to 300-fold more resistant to dis-
infectants than are those in suspension.3 Therefore, 
results from in vitro studies should be confirmed with 
data resembling clinical use or preferably in a clinical 
study. Neither phenolics nor glucoprotamin have a claim 
for sporicidal activity. However, preliminary data suggest 
that glucoprotamin is more active against spores than are 
phenolics. Glucoprotamin is licensed in Europe as a disin-
fectant for instruments and endoscopes. Despite being 
nonteratogenic, nonmutagenic, and safe as an in-use solu-
tion, glucoprotamin in the concentrated form requires 
care and the use of personal protective equipment during 
handling, similar to other disinfectant concentrates. 
Several limitations of this study must be acknowl-
edged. First, we did not quantify the extent of proteins on 
the instruments. However, the large number of samples 
tested on different days and the fact that these instru-
ments came from a general women's clinic suggest that 
the level of contamination was likely to be representative. 
Second, we did not use cultures for mycobacteria on the 
instruments. Therefore, surface-bound mycobacteria may 
not be rapidly killed under these conditions. However, glu-
coprotamin is significantly more active against atypical 
mycobacteria than is glutaraldehyde.6 Glucoprotamin is 
registered in Europe for reprocessing endoscopes, where 
mycobacteria is a serious problem.78 In contrast to alde-
hydes, mycobacteria that are resistant to glucoprotamin 
have not yet been observed. Spores are not killed at the 
concentration and exposure time studied. However, the 
goal of high-level disinfection is to eliminate all vegetative 
bacteria including mycobacteria.1 Few disinfectants have 
been registered by the Food and Drug Administration as 
https:/www.cambridge.org/core/terms. https://doi.org/10.1086/502128
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 11:20:25, subject to the Cambridge Core terms of use, available at
764 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY October 2003 
sterilants (ie, compounds shown to reliably kill bacterial 
spores). The instruments in this study had come into con-
tact with mucous membranes only, and did not belong to 
the class of critical instruments.9 More than 3 log10 CFU of 
C. difficile were killed in a suspension test. Glucoprotamin 
is not registered as an active compound against spores. 
However, it is still fairly active against one of the clinically 
important spores, as indicated by our tests against C. diffi-
cile. This activity was much better than that of phenolics. 
We studied glucoprotamin, a new disinfectant, 
under clinical conditions. The excellent results despite 
the lack of washing to eliminate debris and proteins con-
firm those of prior in vitro studies. 
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